FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2940028357> ?p ?o ?g. }

• W2940028357 endingPage "1453" @default.
• W2940028357 startingPage "1438" @default.
• W2940028357 abstract "Dimedone and thiazole moieties are privileged scaffolds (acting as primary pharmacophores) in many compounds that are useful to treat several diseases, mainly tropical infectious diseases. Thiazole derivatives are a very important class of compounds due to their wide range of pharmaceutical and therapeutic activities. On the other hand, dimedone is used to synthesize many therapeutically active compounds. Therefore, the combination of both moieties through a single molecule to produce heterocyclic compounds will produce excellent anticancer agents.The present work reports the synthesis of 47 new substances belonging to two classes of compounds: Dimedone and thiazoles, with the purpose of developing new drugs that present high specificity for tumor cells and low toxicity to the organism. To achieve this goal, our strategy was to synthesize a series of 4,5,6,7-tetrahydrobenzo[d]-thiazol-2-yl derivatives using the reaction of the 2-bromodimedone with cyanothioacetamide.The reaction of 2-bromodimedone with cyanothioacetamide gave the 4,5,6,7-tetrahydrobenzo[d]- thiazol-2-yl derivative 4. The reactivity of compound 4 towards some chemical reagents was observed to produce different heterocyclic derivatives.A cytotoxic screening was performed to evaluate the performance of the new derivatives in six tumor cell lines. Thirteen compounds were shown to be promising toward the tumor cell lines which were further evaluated toward five tyrosine kinases.The results of antitumor screening showed that many of the tested compounds were of high inhibition towards the tested cell lines. Compounds 6c, 8c, 11b, 11d, 13b, 14b, 15c, 15g, 21b, 21c, 20d and 21d were the most potent compounds toward c-Met kinase and PC-3 cell line. The most promising compounds 6c, 8c, 11b, 11d, 13b, 14b, 15c, 15g, 20c, 20d, 21b, 21c and 21d were further investigated against tyrosine kinase (c-Kit, Flt-3, VEGFR-2, EGFR, and PDGFR). Compounds 6c, 11b, 11d, 14b, 15c, and 20d were selected to examine their Pim-1 kinase inhibition activity the results revealed that compounds 11b, 11d and 15c had high activities." @default.
• W2940028357 created "2019-04-25" @default.
• W2940028357 creator A5026491914 @default.
• W2940028357 creator A5042532613 @default.
• W2940028357 creator A5062612193 @default.
• W2940028357 date "2019-12-02" @default.
• W2940028357 modified "2023-10-16" @default.
• W2940028357 title "Synthesis and Biological Evaluation of Novel 4,5,6,7-Tetrahydrobenzo[D]-Thiazol-2- Yl Derivatives Derived from Dimedone with Anti-Tumor, C-Met, Tyrosine Kinase and Pim-1 Inhibitions" @default.
• W2940028357 cites W1970581400 @default.
• W2940028357 cites W1970705590 @default.
• W2940028357 cites W1983774108 @default.
• W2940028357 cites W1988695413 @default.
• W2940028357 cites W2005775306 @default.
• W2940028357 cites W2007248897 @default.
• W2940028357 cites W2009425838 @default.
• W2940028357 cites W2013249816 @default.
• W2940028357 cites W2055786275 @default.
• W2940028357 cites W2065916018 @default.
• W2940028357 cites W2075014255 @default.
• W2940028357 cites W2076576885 @default.
• W2940028357 cites W2086013967 @default.
• W2940028357 cites W2090552726 @default.
• W2940028357 cites W2091487700 @default.
• W2940028357 cites W2125288820 @default.
• W2940028357 cites W2126508060 @default.
• W2940028357 cites W2127378043 @default.
• W2940028357 cites W2131498755 @default.
• W2940028357 cites W2132051411 @default.
• W2940028357 cites W2156480607 @default.
• W2940028357 cites W2169339988 @default.
• W2940028357 cites W2172350422 @default.
• W2940028357 cites W2221249745 @default.
• W2940028357 cites W2292936365 @default.
• W2940028357 cites W2510278274 @default.
• W2940028357 cites W2523621674 @default.
• W2940028357 cites W2547635984 @default.
• W2940028357 cites W2607266637 @default.
• W2940028357 cites W2774172691 @default.
• W2940028357 cites W2794642808 @default.
• W2940028357 cites W2952989469 @default.
• W2940028357 doi "https://doi.org/10.2174/1871520619666190416102144" @default.
• W2940028357 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31038076" @default.
• W2940028357 hasPublicationYear "2019" @default.
• W2940028357 type Work @default.
• W2940028357 sameAs 2940028357 @default.
• W2940028357 citedByCount "7" @default.
• W2940028357 countsByYear W29400283572020 @default.
• W2940028357 countsByYear W29400283572021 @default.
• W2940028357 countsByYear W29400283572023 @default.
• W2940028357 crossrefType "journal-article" @default.
• W2940028357 hasAuthorship W2940028357A5026491914 @default.
• W2940028357 hasAuthorship W2940028357A5042532613 @default.
• W2940028357 hasAuthorship W2940028357A5062612193 @default.
• W2940028357 hasConcept C161790260 @default.
• W2940028357 hasConcept C178790620 @default.
• W2940028357 hasConcept C185592680 @default.
• W2940028357 hasConcept C21951064 @default.
• W2940028357 hasConcept C2777974117 @default.
• W2940028357 hasConcept C2778464347 @default.
• W2940028357 hasConcept C40875361 @default.
• W2940028357 hasConcept C54355233 @default.
• W2940028357 hasConcept C55493867 @default.
• W2940028357 hasConcept C56173144 @default.
• W2940028357 hasConcept C71240020 @default.
• W2940028357 hasConcept C81885089 @default.
• W2940028357 hasConcept C86803240 @default.
• W2940028357 hasConceptScore W2940028357C161790260 @default.
• W2940028357 hasConceptScore W2940028357C178790620 @default.
• W2940028357 hasConceptScore W2940028357C185592680 @default.
• W2940028357 hasConceptScore W2940028357C21951064 @default.
• W2940028357 hasConceptScore W2940028357C2777974117 @default.
• W2940028357 hasConceptScore W2940028357C2778464347 @default.
• W2940028357 hasConceptScore W2940028357C40875361 @default.
• W2940028357 hasConceptScore W2940028357C54355233 @default.
• W2940028357 hasConceptScore W2940028357C55493867 @default.
• W2940028357 hasConceptScore W2940028357C56173144 @default.
• W2940028357 hasConceptScore W2940028357C71240020 @default.
• W2940028357 hasConceptScore W2940028357C81885089 @default.
• W2940028357 hasConceptScore W2940028357C86803240 @default.
• W2940028357 hasIssue "12" @default.
• W2940028357 hasLocation W29400283571 @default.
• W2940028357 hasLocation W29400283572 @default.
• W2940028357 hasOpenAccess W2940028357 @default.
• W2940028357 hasPrimaryLocation W29400283571 @default.
• W2940028357 hasRelatedWork W1026546888 @default.
• W2940028357 hasRelatedWork W1965316117 @default.
• W2940028357 hasRelatedWork W2791862935 @default.
• W2940028357 hasRelatedWork W2940028357 @default.
• W2940028357 hasRelatedWork W2952818294 @default.
• W2940028357 hasRelatedWork W3026273713 @default.
• W2940028357 hasRelatedWork W3135774823 @default.
• W2940028357 hasRelatedWork W4224277679 @default.
• W2940028357 hasRelatedWork W2424075727 @default.
• W2940028357 hasRelatedWork W2554203401 @default.
• W2940028357 hasVolume "19" @default.
• W2940028357 isParatext "false" @default.
• W2940028357 isRetracted "false" @default.
• W2940028357 magId "2940028357" @default.

• next